Economy
US Gilead Sciences acquires cancer drug developer Arcellx for $7.8B
Data shows biopharmaceutical giant aims to maximize the long-term potential of cell therapy 'anito-cel'
US Gilead Sciences acquires cancer drug developer Arcellx for $7.8B
Data shows biopharmaceutical giant aims to maximize the long-term potential of cell therapy 'anito-cel'
US economy grows 1.4% in Q4 2025, below forecasts
Deceleration in Q4, versus Q3, reflects downturns in government spending and exports, Bureau of Economic Analysis states
China’s US bond holdings fall to lowest since 2008 as other countries buy more
Beijing continues multiyear selloff of US Treasury bonds as Canada and Belgium increase holdings, helping offset China’s withdrawal, expert says
Türkiye’s Aselsan upgrades Kizilelma combat drone with new electronic shield
Aselsan integrates its FEWS-U Electronic Warfare Suite, wraps Bayraktar Kizilelma in 360-degree threat detection and defense deployment system
ECB fines JPMorgan $14.3M over miscalculated assets
European Central Bank penalizes JPMorgan for misreporting its risk-weighted assets for consecutive quarters
New York Stock Exchange ends day with decline
Investors remain cautious due to tensions between US and Iran, while oil prices continue to rise
